“…The concentration of probenecid in the rat brain 1 h after intraperitoneal injection of 200 mg/kg, a dose com monly used in turnover studies [Neff et al, 1967;Neff, 1972, 1973a], has been reported to be 50 pg/g tissue (approxi mately 0.17 mM) [Wijk et al, 1979], Under these conditions, we would expect PST ac tivity to be unaffected assuming that the concentration of probenecid in the whole rat brain equals that in the striatum. However, DA concentration in many other regions of the brain (such as hypothalamus, hippocam pus, cortex, medulla, cerebellum) is below 1.5 pM [Shellenberger and Gordon, 1971;Buu et al, 1981]. It is likely that PST activity could be affected by probenecid treatment in these regions.…”